文章摘要
高血压合并冠心病患者血清CXCR7 LTB4 LRG1表达及其与Gensini评分的关系
Expression of serum CXCR7, LTB4, LRG1 in patients with hypertension and concurrent coronary heart disease and their relationship with Gensini score
投稿时间:2025-05-14  
DOI:10.3969/j.issn.1000-0399.2026.04.008
中文关键词: 高血压  冠心病  C-X-C基序趋化因子受体7  白三烯B4  富亮氨酸α2糖蛋白1  Gensini评分
英文关键词: Hypertension  Coronary heart disease  C-X-C motif chemokine receptor 7  Leukotriene B4  Leucine rich alpha 2 glycoprotein 1  Gensini score
基金项目:2024年度河北省医学科学研究课题计划(编号:241848)
作者单位E-mail
张丽丽 067000 河北承德 承德医学院附属医院全科  
霍静 067000 河北承德 承德医学院附属医院全科  
平萍 067000 河北承德 承德医学院附属医院全科  
李玥萱 067000 河北承德 承德医学院附属医院全科  
张笑颖 067000 河北承德 承德医学院附属医院肝胆外科  
张泽智 067000 河北承德 承德医学院附属医院检验科  
周健 067000 河北承德 承德医学院附属医院全科 zhoujian0716@sina.com 
摘要点击次数: 326
全文下载次数: 89
中文摘要:
      目的 探究高血压合并冠心病患者血清C-X-C基序趋化因子受体7(CXCR7)、白三烯B4(LTB4)、富亮氨酸α2糖蛋白1(LRG1)表达及其与Gensini评分的关系。方法 根据Gensini评分将2022年2月至2025年2月承德医学院附属医院收治的126例高血压合并冠心病患者(研究组)分为轻度、中度和重度冠脉病变组,分别为45例、39例和42例。另选同期126例单纯高血压患者为对照组。采用酶联免疫吸附试验对所有受试者血清CXCR7、LTB4、LRG1水平进行检测。采用Spearman分析血清CXCR7、LTB4、LRG1水平与患者Gensini评分相关性;多因素logistic回归分析影响患者冠脉病变严重程度的因素;绘制受试者工作特征(ROC)曲线分析血清CXCR7、LTB4、LRG1评估患者冠脉病变严重程度的效能。结果 研究组三酰甘油、总胆固醇、低密度脂蛋白胆固醇、血清LTB4、LRG1水平高于对照组,血清CXCR7水平低于对照组(P<0.05)。轻、中、重度冠脉病变组血清LTB4、LRG1水平、低密度脂蛋白胆固醇和Gensini评分依次升高,血清CXCR7水平依次降低(P<0.05)。血清CXCR7、LTB4、LRG1水平是影响患者冠脉病变严重程度的因素(P<0.05)。Spearman分析显示,Gensini评分与血清CXCR7呈负相关(rs=-0.526,P<0.05),与血清LTB4、LRG1呈正相关(rs=0.535、0.513,P<0.05)。血清CXCR7、LTB4、LRG1联合评估患者冠脉病变严重程度的曲线下面积(AUC)高于CXCR7、LTB4、LRG1单独评估(Z=4.422、3.646、3.887,P<0.05)。结论 CXCR7、LTB4、LRG1在高血压合并冠心病患者血清中表达异常,与患者Gensini评分相关,可作为临床辅助评估患者冠脉病变严重程度的生物指标。
英文摘要:
      Objective To discuss the expression of serum C-X-C motif chemokine receptor 7 (CXCR7), leukotriene B4 (LTB4), and leucine rich alpha 2 glycoprotein 1 (LRG1) in patients with hypertension and concurrent coronary heart disease, and their relationship with Gensini score. Methods According to the Gensini score, 126 hypertensive patients with coronary heart disease admitted to Affiliated Hospital of Chengde Medical College from February 2022 to February 2025 (study group) were divided into mild, moderate, and severe coronary artery disease groups, with 45 cases, 39 cases, and 42 cases, respectively. Another 126 patients with simple hypertension were served as the control group. Enzyme linked immunosorbent assay was used to detect serum CXCR7, LTB4, and LRG1 in all subjects. Spearman method was used to explore the correlation between serum CXCR7, LTB4, LRG1 and Gensini score. Multivariate logistic regression was used to explore the influencing factors of the severity of coronary artery disease in patients. Receiver operating characteristic (ROC) curve was plotted to explore the efficacy of serum CXCR7, LTB4, and LRG1 in assessing the severity of coronary artery disease in patients. Results The study group had higher triglycerides, total cholesterol, low-density lipoprotein cholesterol, serum LTB4, and LRG1 than the control group, and lower serum CXCR7 than the control group (P<0.05). The levels of serum LTB4, LRG1, low-density lipoprotein cholesterol, and Gensini score increased sequentially in the mild, moderate, and severe coronary artery disease groups, while the level of serum CXCR7 decreased sequentially (P<0.05). Serum CXCR7, LTB4, and LRG1 were influencing factors for the severity of coronary artery disease in patients (P<0.05). Spearman analysis showed that Gensini score was negatively correlated with serum CXCR7 levels (rs=-0.526, P<0.05)and positively correlated with serum LTB4 and LRG1 levels (rs=0.535, 0.513, P<0.05). The combination of serum CXCR7, LTB4, and LRG1 had a higher area under the curve (AUC) in evaluating the severity of coronary artery disease in these patients than the individual evaluation of CXCR7, LTB4, and LRG1 (Z=4.422, 3.646, 3.887, P<0.05). Conclusion CXCR7, LTB4, and LRG1 are abnormally expressed in the serum of patients with hypertension and coronary heart disease, and they are related to Gensini score. They can serve as biological indicators for clinical assessment of the severity of coronary artery disease in patients.
查看全文   查看/发表评论  下载PDF阅读器
关闭